Mindfulness Intervention for People With Psychosis
Mindfulness-based Interventions for People With Recent-onset Psychosis: A Randomized Controlled Trial
1 other identifier
interventional
108
2 countries
2
Brief Summary
People with psychosis demonstrated a tendency to use maladaptive cognitive emotion regulation strategies as compared with healthy control groups. The present study is the first randomized controlled trial of group mindfulness-based intervention for psychosis. Half group will join the mindfulness-based cognitive intervention while another half will participate in psychoeducation to examine whether mindfulness will have a positive impact on emotion regulation and distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2017
CompletedFirst Submitted
Initial submission to the registry
March 9, 2018
CompletedFirst Posted
Study publicly available on registry
April 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedSeptember 27, 2021
September 1, 2021
4.5 years
March 9, 2018
September 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Depression Anxiety Stress Scale - short form (DASS-21)
). It is chosen as the primary outcome measurement because scales of anxiety and depression possess the capacity to differentiate from the related state of tension and stress linking with environmental demands and emotional and physical disturbance. It is a 21-item instrument that measures over the past week symptoms of depression, anxiety and stress rated by 4-point severity or frequency scale. The scale is from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time).
Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention
Secondary Outcomes (7)
The Emotion Regulation Questionnaire (ERQ)
Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention
The WHOQOL-100
Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention
Positive and Negative Syndrome Scale (PANSS)
Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention
Acceptance and Action Scale (AAQII)
Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention
Five Facet Mindfulness Questionnaire (FFMQ)
Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention
- +2 more secondary outcomes
Study Arms (2)
Mindfulness-based intervention
EXPERIMENTALIntervention: a twelve 1.5 weekly program on mindfulness-based cognitive therapy (psychosis)
Psychoeducation
ACTIVE COMPARATORIntervention: a twelve 1.5 hours weekly program on psychoeducation (psychosis)
Interventions
A small group intervention is based on a structured and validated protocol that will include mindfulness practice, cognitive skills
A small group intervention will be focusing on understanding of psychosis, treatment, relapse prevention and useful information and resources.
Eligibility Criteria
You may qualify if:
- Must be Chinese residents and aged above 18
- Have a primary diagnosis of psychosis (non-affective) and/or other psychotic disorders met the Diagnostic and Statistical Manual DSM-5
- Have been diagnosed equivalent to or less than 5 years
- Mentally stable as assessed by the researcher and a psychiatrist to comprehend the education and training provided (a pre-recruitment briefing session for potential participants will be conducted to verify their ability to follow instructions and understanding in participation, and case files will be reviewed to ensure a stable medication regime for at least 6 months) in order to ensure their ability to make a valid consent
- Able to read and understand Chinese
You may not qualify if:
- Have recently participated in (less than 3 months) or are receiving other structured psycho-education and/or psychotherapies
- Have comorbidities (a) developmental impairment (b) learning disability, (c) personality disorders, and/or (d) any clinically significant medical diseases (by case-file review).
- Have organic psychosis or a primary drug or alcohol addiction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hong Kong Polytechnic Universitylead
- Edinburgh Napier Universitycollaborator
Study Sites (2)
The Fourth People's Hospital
Chengdu, China
The Society of Rehabilitation and Crime Prevention
Hong Kong, Hong Kong
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Thanos Karatzias
Edinburgh Napier University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Assignment to the study groups will be made independently of staff involved in the recruitment and management of participants in the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Clinical Associate
Study Record Dates
First Submitted
March 9, 2018
First Posted
April 18, 2018
Study Start
January 15, 2017
Primary Completion
July 31, 2021
Study Completion
July 31, 2021
Last Updated
September 27, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, CSR
- Time Frame
- 3-months after publication
- Access Criteria
- Request by sending email
All IPD that underlie results in a publication